Successful pregnancy depends on a single, decisive moment when the embryo must implant into a receptive endometrium.
Yet for a significant number of couples undergoing fertility treatment, this step fails — sometimes once, sometimes repeatedly, and often without a clear explanation.
Repeated implantation failure (RIF) deserves particular attention because it sits at the intersection of so many unresolved questions in reproductive medicine. A single failed embryo transfer may simply reflect embryo-related chance events.
But when implantation fails repeatedly despite good quality embryos, it signals that something in the maternal environment, the embryo-endometrium dialogue, or an underlying systemic condition may need deeper investigation. This matters for numerous reasons including emotional and financial burden, diagnostic complexity and a moving evidence base.
In recent years, evidence for various RIF-related tests and interventions has been reviewed extensively, but findings often conflict underscoring the need for coordinated, evidence-based approaches rather than fragmented, trial-and-error management.
It requires personalised care and not a one-size-fits-all protocol.
By focusing specifically on repeated implantation failure, our SIG aims to move the field toward clearer diagnostic pathways and more reliable treatment algorithms ultimately shortening the journey to a successful pregnancy for couples across the region.
Building directly on the SIG's focus, ASPIRE hosted its 15th ASPIRE Masterclass: Recurrent Implantation Failure (RIF) – From Mechanisms to Management in October. It featured two days of evidence-based learning, clinical debate, and practical training in recurrent implantation failure from diagnosis to personalised management.
The masterclass offered SIG members and the wider reproductive medicine community a timely, practical opportunity to deepen their expertise in exactly the area our SIG champions – turning the complex, multifactorial evidence around RIF into actionable, personalised patient care.
Together, we can help close the gap between emerging evidence and everyday clinical practice.